Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
See detailMédecine nucléaire par l'image
Seret, Alain ULg

Book published by Editions de l'Université de Liège (2008)

This book has been primarily written for the technologists and physicians working in nuclear medicine. It would however allow any interested reader to discover this fascinating medical imaging modality ... [more ▼]

This book has been primarily written for the technologists and physicians working in nuclear medicine. It would however allow any interested reader to discover this fascinating medical imaging modality. The book deals with all aspects of diagnostic nuclear medicine with images: scintigraphy and positron emission tomography. The structure of the text is the description of the nuclear procedures from their starting point to their end. Each technical and physical aspect is described on the basis of images and pictures. [less ▲]

Detailed reference viewed: 161 (26 ULg)
Full Text
Peer Reviewed
See detailMédecine personalisée: nouveaux defis pour le praticien.
Scheen, Andre ULg

in Revue medicale de Liege (2015), 70(5-6), 242-6

The clinician has to cope with new advances in medicine. Traditional medicine, which is based upon pathophysiological reasoning and clinical experience, has been reinforced by evidence-based medicine ... [more ▼]

The clinician has to cope with new advances in medicine. Traditional medicine, which is based upon pathophysiological reasoning and clinical experience, has been reinforced by evidence-based medicine, which relies on levels of evidence provided by controlled clinical trials carried out on cohorts of patients. Since a few years, personalized medicine has been put at the forefront. A therapy tailored to every patient, if possible characterized by biomarkers, among which, since the achievement of the whole human genome sequencing, an increasing number of genetic markers. Personalized medicine should be used as a complement of traditional and evidence-based medicine. Physicians should progressively integrate this new strategy in their therapeutic approach. Hence, clinicians have to face new challenges as far as scientific knowledge, practical applications and physician-patient relationship are concerned. [less ▲]

Detailed reference viewed: 28 (4 ULg)
Full Text
Peer Reviewed
See detailMédecine personalisée: tout bénéfice pour le patient, mais nouveau challenge pour la relation médecin-malade.
Scheen, Andre ULg; Giet, Didier ULg

in Revue medicale de Liege (2015), 70(5-6), 247-50

Personalized medicine should lead to major advances for patient care since it contributes to deliver the <<right drug to the right patient>>. In curative medicine, this approach should improve the ... [more ▼]

Personalized medicine should lead to major advances for patient care since it contributes to deliver the <<right drug to the right patient>>. In curative medicine, this approach should improve the efficacy of medications by initial selection of "good responders", and should reduce adverse events due to poor tolerance or toxicity by a better pharmacological choice and a more appropriate individualized dose adjustment. Over recent years, considerable technical advances have increasingly linked personalized medicine with predictive and preventive medicine. This progress raises hopes for major advancements in medicine, but may also cause some concern among the lay public. The patient should actively be involved in the decisions related to his/her health, in a true model of participatory medicine. Finally, personalized medicine should leave its strict technical nature and become more interested in the person as a whole, within a holistic approach also integrating psychosocial aspects that are so important in the physician-patient relationship. [less ▲]

Detailed reference viewed: 132 (3 ULg)
Full Text
Peer Reviewed
See detailLa médecine personnalisée : aspects pharmacoéconomiques
Bruyère, Olivier ULg; Reginster, Jean-Yves ULg; Ethgen, Olivier ULg

in Revue Médicale de Liège (2015), 70(5-6), 339-342

Personalized medicine : pharmacoeconomic aspects Summary : The development and establishment of personalized medicine should allow the improvement of the quality of the care services as well as of the ... [more ▼]

Personalized medicine : pharmacoeconomic aspects Summary : The development and establishment of personalized medicine should allow the improvement of the quality of the care services as well as of the development of new and adapted therapeutic solutions. In a society, whose resources for health care are not endless, the issue of costs and economic effectiveness of personalized medicine is important. Numerous pharmacoeconomic studies have been conducted and many of them suggest that personalized medicine leads to better health, but at higher cost. However, the pharmacoeconomic methods developed over recent years will have to be adapted to better take into account the complexity of the problem, especially the capacity and the reliability of tests to best target patients, and also the whole care process of patients. [less ▲]

Detailed reference viewed: 59 (10 ULg)
Full Text
Peer Reviewed
See detailLa médecine personnalisée face à la médecine factuelle : aspects éthiques
RADERMECKER, Régis ULg

in Revue Médicale de Liège (2015), 70

More patients are actually treated due to the incredible improvements of medical care, especially in the field of pharmacotherapy. Medical guidelines are based on the results of controlled trials. This ... [more ▼]

More patients are actually treated due to the incredible improvements of medical care, especially in the field of pharmacotherapy. Medical guidelines are based on the results of controlled trials. This kind of medicine, also called Evidence Based Medicine, is actually the cornerstone of good clinical practice. Nevertheless, it remains a lot of patients disappointed by the fact that they have no medical gain of their treatment. The reason is that each patient has his own metabolic characteristics. Better is the characterization of such patients, better will be the treatment targeting for them. It is what is called the personalized medicine. To reach this challenge, it will appeal to the pharmacogenetic improvements. From an antagonism between EBM and personalized medicine, this new medical paradigm has to consider these approaches as partners. To reach this goal, medical doctors, legal authorities and pharmaceutical companies have to be responsible in front of these new ethics challenges. [less ▲]

Detailed reference viewed: 46 (1 ULg)
Full Text
Peer Reviewed
See detailLa medecine preventive dans tous ses etats.
Kulbertus, Henri ULg; Scheen, André ULg

in Revue Médicale de Liège (2003), 58(4), 173-4

Detailed reference viewed: 14 (0 ULg)
Full Text
Peer Reviewed
See detailLa médecine sportive: une partie intégrante de la médecine vétérinaire
Art, Tatiana ULg; Lekeux, Pierre ULg

in Annales de Médecine Vétérinaire (1990), 134

Detailed reference viewed: 37 (5 ULg)
Full Text
Peer Reviewed
See detailMédecine traditionnelle ou exercice illégal de l'art de guérir? Les empiriques liégeois au XIXe siècle
Havelange, Carl ULg

in Revue Médicale de Liège (1983), XXXVIII(22),

Detailed reference viewed: 13 (2 ULg)
Full Text
Peer Reviewed
See detailMédecine, Thérapeutiques et Plantes médicinales
Lecomte, Jean; Angenot, Luc ULg

in Journal de Pharmacie de Belgique (1986), 41(Supplement), 3-10

In the Western World, as many people became concerned at the potency and side effects of new drugs, there is an increasing interest in the alternative systems, including phytotherapy, and as the ... [more ▼]

In the Western World, as many people became concerned at the potency and side effects of new drugs, there is an increasing interest in the alternative systems, including phytotherapy, and as the pharmacist must be the best qualified to advise on, and supply all drugs (e.g. herbal products) we give below our scientific opinion about the real position of plants in modern therapy. Records extant from Ancien egypt, Assyria, Greece and roma show that the use of plants for medicinal purposes exetnd back to our earliest recorded history. during the course of history, the cure of disease and the use of medicinal plants has been much influenced by religious practice and the exercise of magical rites. Thus the philosophy of the "Doctrine of Signatures" introduced by Paracelsus in the sixteenth century had considerable sway for four centuries and was not completely abandoned until the modern era of phytochemistry and pharmacology gave an alternative system for the rationalization of the use of plants in medicine. However, for most of herbal remedies, it is not still possible to demonstrate or evaluate their pharmacological activity, and the situation is complicated by the frequent use of a number of drugs in combination, the supposed active constituents of which have not been elucidated. Arising from this, orthodox medicine came to disregard sub "polypharmaceutical" preparations and concentrated research on the isolation of natural individual components having, for example, demonstrable anticancer, hypotensive ; antiplasmodial or antimicrobial properties. [less ▲]

Detailed reference viewed: 40 (0 ULg)
Full Text
See detailMédecins et charlatans à Liège au XVIIIe siècle. Quelques éléments d'interprétation
Havelange, Carl ULg

Scientific conference (1985, May)

Detailed reference viewed: 12 (3 ULg)
Full Text
See detailMédecins et vétérinaires célestes d’Ardenne
Donneau, Olivier ULg

in Guérisseurs d’hier et d’aujourd’hui (2003)

Short history of the evolution of the cults devoted to the healing saints in the Ardenne (Belgium).

Detailed reference viewed: 105 (14 ULg)
Full Text
Peer Reviewed
See detailLes médecins généralistes belges francophones peuvent-ils améliorer leurs performances en prévention ? Une étude qualitative
Vanmeerbeek, Marc ULg; Belche, Jean ULg; Lemaître, Anne-Françoise ULg et al

in Exercer (2013), 107

Background In French-speaking Belgium, success in implementing preventive care remains below expectations, with a socioeconomic gradient. Could GPs contribute to reduce these differences? Objectives The ... [more ▼]

Background In French-speaking Belgium, success in implementing preventive care remains below expectations, with a socioeconomic gradient. Could GPs contribute to reduce these differences? Objectives The study aims at knowing the representations of French-speaking GPs towards their preventive healthcare. The results will be used in a survey assessing the determinants of their involvement in a more systematic and equitable preventive healthcare delivery. Methods We conducted semi-directed interviews with French-speaking GPs. The content was analyzed in a thematic way with reference to the Walsh & McPhee systems model of clinical preventive care to retrieve the predisposing, reinforcing, and enabling factors. Results Preventive healthcare was limited by GPs’ specific interests and psychology. Some clinical and relational skills were sometimes lacking. The information sources were sometimes of poor quality. The lack of organizational skills hindered collective management or systematization towards equity. Media and pharmaceuticals influenced preventive healthcare. GPs wished a specific funding; possibly by “Pay for Quality”. Self assessment was too rare to be a reinforcement factor. Preventive processes were often introduced in an opportunistic way, due to the lack of time. Data circulation and coordination between the various providers was poor. A primary care focused healthcare delivery was suggested. Conclusions Conditions to tackle health inequalities towards preventive healthcare don’t seem to be present at now. To achieve this goal, GPs should be more proactive and develop their practice in a more community-oriented way. However, more research is needed to assess their personal motivation for change. Health authorities should determine a delimitation of competencies and responsibilities and provide organisational support. [less ▲]

Detailed reference viewed: 143 (36 ULg)
Full Text
Peer Reviewed
See detailMédecins généralistes wallons. Quelles prescriptions aux personnes âgées de plus de 75 ans?
Franck, Jacques ULg; Ludovicy, R.; Taziaut, P. et al

in Revue Médicale de Liège (1996), 51(2), 163-74

Detailed reference viewed: 15 (1 ULg)